Form 4 for IOVA IOVANCE BIOTHERAPEUTICS, INC.
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001104659-25-021058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | IOVA | BILINSKY IGOR | COO | M - OptEx | $0.00 | +62.1K | 120.9K | +106% | $0 |
| D | 2025-03-05 | 2025-03-03 | IOVA | BILINSKY IGOR | COO | F - Tax | $4.04 | -33.3K | 87.6K | -28% | -$134.5K |
| DM | 2025-03-05 | 2025-03-03 | IOVA | BILINSKY IGOR | COO | M - OptEx | $0.00 | -62.1K | 70.3K | -47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | M | A | 62,106 | $0.00 | 120,880 | D | — | — | (F1) Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
| 2 | Common | Common Stock | 2025-03-03 | F | D | 33,302 | $4.04 | 87,578 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. (F3) Represents common stock remaining after deducting the common stock withheld for taxes. |
| 3 | Derivative | Restricted Stock Units | 2025-03-03 | M | D | 3,516 | $0.00 | 14,065 | D | — · — to — | 3,516 Common stock | (F6) Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. (F4) Each RSU represents a contingent right to receive one share of the Issuer's common stock. (F5) The remaining RSUs will vest in equal quarterly installments. |
| 4 | Derivative | Restricted Stock Units | 2025-03-03 | M | D | 58,590 | $0.00 | 70,317 | D | — · — to — | 58,590 Common stock | (F7) Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. (F4) Each RSU represents a contingent right to receive one share of the Issuer's common stock. (F5) The remaining RSUs will vest in equal quarterly installments. |